Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

AVBPAVBP
10 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ARRIVENT BIOPHARMA INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 294,224 shares of AVBP (ARRIVENT BIOPHARMA INC), worth $10.2M as of 2026-Q2. The position was increased (+13.7% shares). AVBP represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$10.2M

Current Shares

294,224

Total Value Change

+$8.8M

Total Shares Change

+216,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
294,224
+13.7%
$10.2M0.0%$34.74
31
2026-Q1
Increased
258,772
+3.3%
$6M0.0%$23.94
28
2025-Q4
Increased
250,588
+2.9%
$5M0.0%$20.72
28
2025-Q3
Increased
243,486
+29.4%
$4.5M0.0%$18.16
34
2025-Q2
Decreased
188,202
-4.2%
$4.1M0.0%$22.91
0
2025-Q1
Decreased
196,494
-4.8%
$3.6M0.0%$18.95
0
2024-Q4
Increased
206,379
+2.0%
$5.5M0.0%$26.95
28
2024-Q3
Increased
202,368
+153.8%
$4.8M0.0%$23.00
43
2024-Q2
Increased
79,727
+2.5%
$1.5M0.0%$18.55
26
2024-Q1
New
77,760
-
$1.4M0.0%$17.86
35

Other major holders of AVBP: HHLR ADVISORS, LTD., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used